CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $30.00 ($300,000)
- 4 Open-market sale Director sold 10,000 shares at $30.00 ($300,000)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 7,784 shares at $29.00 ($225,736)
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 2,216 shares at $29.00 ($64,264)
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at an average $28.48 ($284,843)
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 100 shares at $31.00 ($3,100)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 25 of 33 · 660 filings